Chen HF - Search Results

1

Eye metastasis in lung adenocarcinoma mimicking anterior scleritis: A case report.

Chen HF, Wang WX, Li XF, Wu LX, Zhu YC, Du KQ, Xu CW. Chen HF, et al. World J Clin Cases. 2020 Jan 26;8(2):410-414. doi: 10.12998/wjcc.v8.i2.410. World J Clin Cases. 2020. PMID: 32047793 Free PMC article.

2

Concurrent ROS1 gene rearrangement and KRAS mutation in lung adenocarcinoma: A case report and literature review.

Zhu YC, Lin XP, Li XF, Wu LX, Chen HF, Wang WX, Xu CW, Shen JF, Wei JG, Du KQ. Zhu YC, et al. Among authors: chen hf. Thorac Cancer. 2018 Jan;9(1):159-163. doi: 10.1111/1759-7714.12518. Epub 2017 Oct 3. Thorac Cancer. 2018. PMID: 28971587 Free PMC article.

3

Association between BIM polymorphism and lung cancer outcomes: a meta-analysis.

Li XF, Wu LX, Chen HF, Zhu YC, Wang WX, Xu CW, Lin XP, Xie DF, Du KQ. Li XF, et al. Among authors: chen hf. Cell Mol Biol (Noisy-le-grand). 2018 Aug 30;64(11):92-96. Cell Mol Biol (Noisy-le-grand). 2018. PMID: 30213299

4

A meta-analysis of association between serum iron levels and lung cancer risk.

Chen HF, Wu LX, Li XF, Zhu YC, Wang WX, Xu CW, Xie DF, Huang JH, Du KQ. Chen HF, et al. Cell Mol Biol (Noisy-le-grand). 2018 Oct 30;64(13):33-37. Cell Mol Biol (Noisy-le-grand). 2018. PMID: 30403607

5

Intestinal metastasis from primary ROS1-positive lung adenocarcinoma cancer patients responding to crizotinib.

Chen HF, Zhang QX, Zhu YC, Du KQ, Li XF, Wu LX, Wang WX, Xu CW. Chen HF, et al. Onco Targets Ther. 2018 Nov 5;11:7821-7825. doi: 10.2147/OTT.S178985. eCollection 2018. Onco Targets Ther. 2018. PMID: 30464529 Free PMC article.

6

Combined detection of CEA and CA125 for the diagnosis for lung cancer: A meta-analysis.

Wu LX, Li XF, Chen HF, Zhu YC, Wang WX, Xu CW, Xie DF, Wan Y, Du KQ. Wu LX, et al. Among authors: chen hf. Cell Mol Biol (Noisy-le-grand). 2018 Dec 31;64(15):67-70. Cell Mol Biol (Noisy-le-grand). 2018. PMID: 30672447

7

Clinicopathological features and clinical efficacy of crizotinib in Chinese patients with ROS1-positive non-small cell lung cancer.

Zhu YC, Zhang XG, Lin XP, Wang WX, Li XF, Wu LX, Chen HF, Xu CW, Du KQ. Zhu YC, et al. Among authors: chen hf. Oncol Lett. 2019 Mar;17(3):3466-3474. doi: 10.3892/ol.2019.9949. Epub 2019 Jan 18. Oncol Lett. 2019. PMID: 30867785 Free PMC article.

8

Ginsenoside compound K inhibits growth of lung cancer cells via HIF-1α-mediated glucose metabolism.

Chen HF, Wu LX, Li XF, Zhu YC, Wang WX, Xu CW, Huang ZZ, Du KQ. Chen HF, et al. Cell Mol Biol (Noisy-le-grand). 2019 Apr 30;65(4):48-52. Cell Mol Biol (Noisy-le-grand). 2019. PMID: 31078152

9

Hepatoid Adenocarcinoma of the Lung with EGFR Mutation and the Response to Tyrosine Kinase Inhibitors.

Chen HF, Wang WX, Li XL, Xu CW, Du KQ, Zhu YC, Fang MY. Chen HF, et al. J Thorac Oncol. 2019 Oct;14(10):e217-e219. doi: 10.1016/j.jtho.2019.04.032. J Thorac Oncol. 2019. PMID: 31558230 Free article. No abstract available.

10

A Real-World Study in Advanced Non-Small Cell Lung Cancer with KRAS Mutations.

Lei L, Wang WX, Yu ZY, Liang XB, Pan WW, Chen HF, Wang LP, Fang Y, Wang M, Xu CW, Fang MY. Lei L, et al. Among authors: chen hf. Transl Oncol. 2020 Feb;13(2):329-335. doi: 10.1016/j.tranon.2019.12.004. Epub 2019 Dec 24. Transl Oncol. 2020. PMID: 31881505 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

952 results

Search Page

Filters